You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 142 No. 2, February 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on ISI (1)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Hair Disorders
 •Drug Therapy
 •Adverse Effects
 •Alert me on articles by topic

VIGNETTES
Tufted Folliculitis of the Scalp and Treatment With Cyclosporine

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

About 80% of patients treated with cyclosporine develop cutaneous adverse effects.1 These include manifestations of excessive epithelial proliferation: hypertrichosis, gingival hypertrophy, hyperplastic pseudofolliculitis barbae, pilar keratosis, epidermal (follicular infundibular) cysts, sebaceous gland hyperplasia, and, as recently described,2 folliculodystrophy syndrome. We report a case of tufted folliculitis of the scalp in a patient who was treated with cyclosporine.

Report of a Case

A 26-year-old white man received a kidney transplant 9 months before presentation to treat Schönlein-Henoch purpura. Since then, he had been treated with a regimen of cyclosporine and prednisone. He was referred to our dermatology unit because he had skin lesions on his scalp. He also presented with Williams-Beuren syndrome, which had been diagnosed during his first year of life. Clinical examination (Figure 1) of the scalp found papulonodules and follicular pustules grouped around tufts of 10 to 15 hairs emerging from the same ostium, as well as areas of scarring . . . [Full Text of this Article]


Comment

AUTHOR INFORMATION
David Farhi, MD; Valérie Buffard, MD; Nicolas Ortonne, MD; Jean Revuz, MD, PhD







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.